Stifel on Sionna Therapeutics (SION): 'we like the stock set up here'
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Buy rating and $32.00 price target on Sionna Therapeutics (NASDAQ: SION).The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
